Header Logo

Connection

JOHN VIERLING to Abatacept

Back to Details
This is a "connection" page, showing publications JOHN VIERLING has written about Abatacept.
JOHN VIERLING
Connection Strength
0.038
Abatacept
  1. Therapeutic trials of biologics in primary biliary cholangitis: An open label study of abatacept and review of the literature. J Autoimmun. 2019 07; 101:26-34.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.